• bitcoinBitcoin(BTC)$81,418.003.94%
  • ethereumEthereum(ETH)$2,652.595.75%
  • tetherTether(USDT)$1.000.05%
  • binancecoinBNB(BNB)$767.881.82%
  • rippleXRP(XRP)$1.425.97%
  • usd-coinUSDC(USDC)$1.000.02%
  • solanaSolana(SOL)$112.295.81%
  • tronTRON(TRX)$0.3382580.46%
  • zcashZcash(ZEC)$1,553.065.72%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.030.22%
  • HyperliquidHyperliquid(HYPE)$91.843.75%
  • dogecoinDogecoin(DOGE)$0.0873082.43%
  • moneroMonero(XMR)$579.117.28%
  • RainRain(RAIN)$0.0140008.02%
  • whitebitWhiteBIT Coin(WBT)$83.523.56%
  • USDSUSDS(USDS)$1.000.02%
  • chainlinkChainlink(LINK)$12.445.16%
  • cardanoCardano(ADA)$0.2239474.10%
  • leo-tokenLEO Token(LEO)$8.89-0.14%
  • stellarStellar(XLM)$0.1927492.33%
  • uniswapUniswap(UNI)$9.264.13%
  • bitcoin-cashBitcoin Cash(BCH)$248.75-0.54%
  • nearNEAR Protocol(NEAR)$3.676.59%
  • Ethena USDeEthena USDe(USDE)$1.000.05%
  • daiDai(DAI)$1.000.01%
  • litecoinLitecoin(LTC)$57.162.23%
  • CantonCanton(CC)$0.110391-0.75%
  • USD1USD1(USD1)$1.000.06%
  • avalanche-2Avalanche(AVAX)$8.8811.98%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.370.48%
  • hedera-hashgraphHedera(HBAR)$0.0792782.50%
  • suiSui(SUI)$0.835.36%
  • Global DollarGlobal Dollar(USDG)$1.00-0.01%
  • shiba-inuShiba Inu(SHIB)$0.0000050.86%
  • crypto-com-chainCronos(CRO)$0.0595460.20%
  • MemeCoreMemeCore(M)$1.30-1.85%
  • BittensorBittensor(TAO)$259.334.90%
  • paypal-usdPayPal USD(PYUSD)$1.000.03%
  • tether-goldTether Gold(XAUT)$4,370.77-0.45%
  • Circle USYCCircle USYC(USYC)$1.140.03%
  • okbOKB(OKB)$117.002.24%
  • Ripple USDRipple USD(RLUSD)$1.000.00%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • aaveAave(AAVE)$146.609.19%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.07%
  • AsterAster(ASTER)$0.760.59%
  • mantleMantle(MNT)$0.612.40%
  • OndoOndo(ONDO)$0.4022994.36%
  • MorphoMorpho(MORPHO)$2.7918.00%
  • EthenaEthena(ENA)$0.19348715.68%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

The breakthrough Alzheimer’s device the FDA hasn’t approved – yet

October 30, 2025
in Trade Tube
Reading Time: 4 mins read
A A
ShareShareShareShareShare



Cerezen’s device has shown promise in some Alzheimer’s patients and is now approved for use in Europe.

Transcript:

YOU MAY ALSO LIKE

Don’t Panic! My Plan For This Market Crash

New Jev Model Acts in Real Time… Minecraft Broke It

Caroline Woods: Joining me now is Manoj Bhargava, Founder and CEO of Cerezen. His company is also the largest shareholder of our parent company, The Arena Group. Thanks so much for joining us.

Manoj Bhargava: My pleasure.

Caroline Woods: So Manoj, Cerezen is a medical device used to treat dementia and Alzheimer’s. It just received certification for usage in the EU. We’ll get to all of that. But first, for those who haven’t heard of it yet, for those who aren’t familiar, what exactly is it and how does it work to treat Alzheimer’s or dementia?

Manoj Bhargava: Well, it’s a treatment for Alzheimer’s. The guy who this is named after thought it was a cardiovascular problem. So it’s a vascular problem. And so we looked at what can we do to enhance vascular. So there’s a treatment which involves cuffs. And what it does is sends enhances blood flow to the brain. Right and it’s like watering a plant. If you don’t water it you have a problem. So if you water it chances are it’ll do something good for the planet. And so that’s basically how it works. It sends blood flow to the brain. And actually it’s pretty simple.

Caroline Woods: How soon do patients typically notice results?

Manoj Bhargava: It’s within a few weeks. And in, we’ve had in some cases where we’ve reversed Alzheimer’s. And it’s actually the first person we had a small trial of four people, and then one person actually reversed. So they became functional. And we took that person to the FDA and they said, this is the first time ever that this somebody has reversed. And so they gave us breakthrough status.

Caroline Woods: I was going to say we’re used to treatments that slow the decline, but reversal is unheard of. So what is it that you actually saw? I’m curious.

Manoj Bhargava: Well, people become basically nonfunctional at some point where you’re just sitting there. Right what we did basically was water the plant. I mean, the best analogy is a plant that. You know, if you don’t water it, the leaves turn yellow after a while, or they turn Brown and they and it dies. So if you water it, all of a sudden the leaves are back to growing and back to Green. A lot of the people who think a lot of the scientists seem to think that if you inject Greene into the yellow leaf, it’ll fix it. Or you could just water the plant. That’s what this really is. It’s kind of simple if you don’t have blood flow to the brain. All kinds of bad things happen. Think about it. If what blood flow does is takes away trash from the brain, all of a sudden it’s not working as well. And you collect trash in the brain. And what did you think was going to happen. So it’s based on I mean, I’m being simplistic here, but that’s how much I understand it is that it’s simple. It’s blood flow. And so that’s the fundamental of it. And so it’s side effects are only they’re the same side effects you would have, walking on a treadmill. So no open wounds and no aneurysm. And that’s pretty much it for no side effects.

Caroline Woods: So a simple explanation. But we know that Alzheimer’s has been one of the toughest diseases to treat effectively. So I guess what makes Cerezen’s approach different from what other traditional pharmaceutical or drug based therapies are doing?

Manoj Bhargava: Well, first of all, scientists tend to, in my opinion, like complicated answers. So instead of one of a friend of mine who’s one of the top guys in the world in cancer and he says, you need to first treat wellness. In other words, if wellness starts dropping, all kinds of diseases show up, right? So what we did blood flow is one of the fundamentals of being in health. So we looked at and said, how do we increase wellness. In other words, wellness is sort of your brain is getting all the blood flow it requires. And so the answer is really simple. And we’ve really noticed I mean, scientists don’t get to write papers on simple solutions. They want complicated stuff. You know, one guy says it’s amyloid. And it’s amyloid, which is like the yellow leaf, right? We’re going to inject something to make it not yellow. And in fact, some people have said in the FDA that if it doesn’t have amyloid, it’s not Alzheimer’s. So even though you have exactly the same symptoms, it’s like going to a doctor saying, I’m AI have a headache. And the guy says, no, you don’t. So Alzheimer’s has these symptoms. And some of these guys say if you have all of the symptoms, but if you don’t have amyloid, it’s not Alzheimer’s. Well, that’s pretty silly. If it looks like a duck, walks like a duck, talks like a duck, the chance is pretty much that it’s a duck.

Subscribe |
Earn. Live. Invest. |
TheStreet Pro |

#cerezen #alzheimers #fda

source

ShareTweetSendSharePin

Related Posts

Don’t Panic! My Plan For This Market Crash
Trade Tube

Don’t Panic! My Plan For This Market Crash

September 19, 2026
New Jev Model Acts in Real Time… Minecraft Broke It
Trade Tube

New Jev Model Acts in Real Time… Minecraft Broke It

September 19, 2026
JEV – Can This NEW Type of AI Help Us Win on Kalshi?
Trade Tube

JEV – Can This NEW Type of AI Help Us Win on Kalshi?

September 18, 2026
AI News: All AI Labs Want To Slow Down (Except One)
Trade Tube

AI News: All AI Labs Want To Slow Down (Except One)

September 18, 2026
Next Post
Meta or Amazon? ChatGPT or Grok? AI: bubble or boom? Jim Cramer gives his quick takes

Meta or Amazon? ChatGPT or Grok? AI: bubble or boom? Jim Cramer gives his quick takes

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Judge officially declares mistrial in Lindsay Clancy case

Judge officially declares mistrial in Lindsay Clancy case

September 17, 2026
What Is The Difference Between A Dead Pixel And A Stuck Pixel?

What Is The Difference Between A Dead Pixel And A Stuck Pixel?

September 13, 2026
Investors Look Beyond AI As Market Signals Blur

Investors Look Beyond AI As Market Signals Blur

September 19, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!